The patient was treated with IV Insulin and carefully monitored for serum glucose and electrolytes.
Status post RFA to liver.
End-stage renal disease on hemodialysis on Tuesday, Thursday, and Saturdays.
The patient's blood sugars were well controlled on her NPH and sliding scale regimen.
RENAL:  The patient continued to receive hemodialysis.
CARDIOVASCULAR:  The patient remained normotensive and, therefore, her antihypertensives were not continued on the floor.
ONCOLOGY:  The patient was seen by the Oncology Staff and no intervention was recommended at this time.
Megace 400 mg p.o.b.i.d.
Reglan 5 mg p.o.q.4h.
Colace 100 mg p.o.b.i.d.
Oxycodone 5 mg p.o.q.4h.
Sertraline 50 mg p.o.q.d.
Sevelamer 1600 mg p.o.t.i.d.
Prochlorperazine 10 mg p.o.q6h.p.r.n.nausea.
Calcium acetate two tablets p.o.t.i.d.
Senna one tablet p.o.
NPH insulin 5 units subcutaneously at bedtime and 9 units subcutaneously at breakfast.
